Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1

Status

Recruiting 6Not yet recruiting 3Unknown 1Completed 1

Sponsor Class

OTHER 2UNKNOWN 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 10Carcinoma, Hepatocellular 10Carcinoma, Non-Small-Cell Lung 5Rectal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Recurrence 2Nasopharyngeal Carcinoma 2Colorectal Neoplasms 2Colonic Neoplasms 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Turcot syndrome 1Thyroid Neoplasms 1Squamous Non-Small Cell Lung Cancer SqNSCLC 1Spinocerebellar Degenerations 1Solid Tumor 1Small Cell Lung Carcinoma 1Resectable Non-small Cell Lung Cancer 1Rare Tumour 1Pancreatic Neoplasms 1Pancreatic Cancer Resectable 1Pancreatic Cancer Metastatic 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Locally Advanced Non-Small Cell Lung Cancer 1Hodgkin Disease 1HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma 1Esophageal Neoplasms 1

Interventions

Capecitabine 13Oxaliplatin 10Radiotherapy 8Surgical Procedures, Operative 6Drug Therapy 5tislelizumab 4Irinotecan 4sintilimab 3Neoadjuvant Therapy 3Immunotherapy 3Fluorouracil 3Endoscopic Mucosal Resection 3Bevacizumab 3spartalizumab 2raltitrexed 2XELOX 2Trinitrotoluene 2Radiation 2Immune Checkpoint Inhibitors 2Folfox protocol 2Cetuximab 2toripalimab 1sperm releasing substance 1saxagliptin 1s-formylglutathione hydrolase 1envafolimab 1disitamab vedotin 1cemiplimab 1camrelizumab 1balstilimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Rectal Neoplasms × sintilimab × Clear all
NCT07509424 2026-04-03

Neoadjuvant Short-course Radiotherapy Followed by a Combination of Disitamab Vedotin, Sintilimab, and Capecitabine in Locally Advanced HER2-expressing Rectal Cance

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 2 Not yet recruiting
29 enrolled
Gastrointestinal

Rectal Neoplasms

NCT06652412 2024-10-28

CGA Guided Ultrafractionated RT and Systemic Treatment in Elderly or Frail Patients with Inoperable Localized CRC

Fudan University

Phase 2 Not yet recruiting
124 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT05484024 2022-08-02

Short-course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer

ChineseAMS

Phase 2/3 Not yet recruiting
588 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡